These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 11289666

  • 1. Assessment of the antimalarial potential of tetraoxane WR 148999.
    Vennerstrom JL, Ager AL, Andersen SL, Grace JM, Wongpanich V, Angerhofer CK, Hu JK, Wesche DL.
    Am J Trop Med Hyg; 2000 May; 62(5):573-8. PubMed ID: 11289666
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups.
    Dong Y, Matile H, Chollet J, Kaminsky R, Wood JK, Vennerstrom JL.
    J Med Chem; 1999 Apr 22; 42(8):1477-80. PubMed ID: 10212135
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes.
    Vennerstrom JL, Dong Y, Andersen SL, Ager AL, Fu H, Miller RE, Wesche DL, Kyle DE, Gerena L, Walters SM, Wood JK, Edwards G, Holme AD, McLean WG, Milhous WK.
    J Med Chem; 2000 Jul 13; 43(14):2753-8. PubMed ID: 10893313
    [Abstract] [Full Text] [Related]

  • 4. Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.
    Sato A, Hiramoto A, Morita M, Matsumoto M, Komich Y, Nakase Y, Tanigawa N, Hiraoka O, Hiramoto K, Hayatsu H, Higaki K, Kawai S, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2011 Sep 13; 60(3):270-3. PubMed ID: 21501696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tetraoxanes: synthetic and medicinal chemistry perspective.
    Kumar N, Singh R, Rawat DS.
    Med Res Rev; 2012 May 13; 32(3):581-610. PubMed ID: 22675731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo.
    Shmuklarsky MJ, Klayman DL, Milhous WK, Kyle DE, Rossan RN, Ager AL, Tang DB, Heiffer MH, Canfield CJ, Schuster BG.
    Am J Trop Med Hyg; 1993 Mar 13; 48(3):377-84. PubMed ID: 8470775
    [Abstract] [Full Text] [Related]

  • 9. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R, Rizvi A, Pandey SK, Dwivedi H, Saxena JK.
    Acta Trop; 2013 May 13; 126(2):150-5. PubMed ID: 23391499
    [Abstract] [Full Text] [Related]

  • 10. The chemotherapy of rodent malaria, XXV. Antimalarial activity of WR 122,455 (a 9-phenanthrenemethanol) in vivo and in vitro.
    Porter M, Peters W.
    Ann Trop Med Parasitol; 1976 Sep 13; 70(3):259-70. PubMed ID: 788657
    [Abstract] [Full Text] [Related]

  • 11. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
    Peters W, Irare SG, Ellis DS, Warhurst DC, Robinson BL.
    Ann Trop Med Parasitol; 1984 Dec 13; 78(6):567-79. PubMed ID: 6398032
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
    Snyder C, Chollet J, Santo-Tomas J, Scheurer C, Wittlin S.
    Exp Parasitol; 2007 Mar 13; 115(3):296-300. PubMed ID: 17087929
    [Abstract] [Full Text] [Related]

  • 13. The chemotherapy of rodent malaria, XXVI. The potential value of WR 122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites.
    Peters W, Porter M.
    Ann Trop Med Parasitol; 1976 Sep 13; 70(3):271-81. PubMed ID: 788658
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites.
    Oliveira R, Newton AS, Guedes RC, Miranda D, Amewu RK, Srivastava A, Gut J, Rosenthal PJ, O'Neill PM, Ward SA, Lopes F, Moreira R.
    ChemMedChem; 2013 Sep 13; 8(9):1528-36. PubMed ID: 23853126
    [Abstract] [Full Text] [Related]

  • 18. Stage specific activity of synthetic antimalarial endoperoxides, N-89 and N-251, against Plasmodium falciparum.
    Morita M, Koyama T, Sanai H, Sato A, Hiramoto A, Masuyama A, Nojima M, Wataya Y, Kim HS.
    Parasitol Int; 2015 Feb 13; 64(1):113-7. PubMed ID: 25449979
    [Abstract] [Full Text] [Related]

  • 19. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD, Padayachee T, Ismail I.
    Mem Inst Oswaldo Cruz; 1999 Feb 13; 94(5):667-74. PubMed ID: 10464415
    [Abstract] [Full Text] [Related]

  • 20. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605.
    Peters W, Robinson BL, Milhous WK.
    Ann Trop Med Parasitol; 1993 Dec 13; 87(6):547-52. PubMed ID: 8122915
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.